Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Arun J. Sanyal, Lee M. Kaplan, Juan P. Frias et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
12 papers1 CorrectedQuestions on this topic
Arun J. Sanyal, Lee M. Kaplan, Juan P. Frias et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
Jinhua Bao, Yingying Huang, Xue Li et al. · JAMA Ophthalmology · 2022 · Randomised trial
Full textCC BY
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono et al. · NEJM Evidence · 2022 · Randomised trial
Full textCC BY
Peter Vink, Josep Maria Ramon Torrell, Ana Sanchez Fructuoso et al. · Clinical Infectious Diseases · 2019 · Randomised trial
Full textCC BY
David B. Antcliffe, Katie L. Burnham, Farah Al-Beidh et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · Randomised trial
Full textCC BY
Aimée R. Kreimer, Rolando Herrero, Joshua N. Sampson et al. · Vaccine · 2018 · Randomised trial
Full textCC BY
Keith W Muir, Gary A Ford, Claudia-Martina Messow et al. · Journal of Neurology, Neurosurgery & Psychiatry · 2016 · Randomised trial
Full textCC BY
Kfir Oved, Asi Cohen, Olga Boico et al. · PLOS ONE · 2015 · Randomised trial
Full textCC BY
Melissa A. Rolfes, Kathy Huppler Hullsiek, Joshua Rhein et al. · Clinical Infectious Diseases · 2014 · Randomised trial
Full textCC BY
Michael E. Hoffer, Carey Balaban, Martin D. Slade et al. · PLoS ONE · 2013 · Randomised trial
Full textCC0
Hendrik Harms, Konstantin Prass, Christian Meisel et al. · PLoS ONE · 2008 · Randomised trial
Full textCC BY
K-U Petry, S Menton, M Menton et al. · British Journal of Cancer · 2003 · Randomised trial
Full textCC BY